EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 253 filers reported holding EDITAS MEDICINE INC in Q1 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $256,000 | -32.8% | 9,634 | +3.8% | 0.02% | -41.7% |
Q3 2021 | $381,000 | -27.6% | 9,284 | 0.0% | 0.04% | -12.2% |
Q2 2021 | $526,000 | +37.7% | 9,284 | +2.2% | 0.04% | +5.1% |
Q1 2021 | $382,000 | -40.0% | 9,084 | 0.0% | 0.04% | -46.6% |
Q4 2020 | $637,000 | +158.9% | 9,084 | +9.2% | 0.07% | +78.0% |
Q2 2020 | $246,000 | – | 8,317 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |